The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Glut1 Deficiency Syndrome (Glut1DS): State of the art in 2020 and recommendations of the international Glut1DS study group
Open accessAbstract
Glut1 deficiency syndrome (Glut1DS) is a brain energy failure syndrome caused by impaired glucose transport across brain tissue barriers. Glucose diffusion across tissue barriers is facilitated by a family of proteins including glucose transporter type 1 (Glut1). Patients are treated effectively with ketogenic diet therapies (KDT) that provide a supplemental fuel, namely ketone bodies, for brain energy metabolism. The increasing complexity of Glut1DS, since its original description in 1991, now demands an international consensus statement regarding diagnosis and treatment. International experts (n = 23) developed a consensus statement utilizing their collective professional experience, responses to a standardized questionnaire, and serial discussions of wide‐ranging issues related to Glut1DS. Key clinical features signaling the onset of Glut1DS are eye‐head movement abnormalities, seizures, neurodevelopmental impairment, deceleration of head growth, and movement disorders. Diagnosis is confirmed by the presence of these clinical signs, hypoglycorrhachia documented by lumbar puncture, and genetic analysis showing pathogenic SLC2A1 variants. KDT represent standard choices with Glut1DS‐specific recommendations regarding duration, composition, and management. Ongoing research has identified future interventions to restore Glut1 protein content and function. C linical manifestations are influenced by patient age, genetic complexity, and novel therapeutic interventions. All clinical phenotypes will benefit from a better understanding of Glut1DS natural history throughout the life cycle and from improved guidelines facilitating early diagnosis and prompt treatment. Often, the presenting seizures are treated initially with antiseizure drugs before the cause of the epilepsy is ascertained and appropriate KDT are initiated. Initial drug treatment fails to treat the underlying metabolic disturbance during early brain development, contributing to the long‐term disease burden. Impaired development of the brain microvasculature is one such complication of delayed Glut1DS treatment in the postnatal period. This international consensus statement should facilitate prompt diagnosis and guide best standard of care for Glut1DS throughout the life cycle.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
De Vivo, D. C., Trifiletti, R. R., Jacobson, R. I., Ronen, G. M., Behmand, R. A., & Harik, S. I. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109053251006 · Cited by 800
Self-citationKossoff, E. H., Zupec‐Kania, B. A., Auvin, S., Ballaban‐Gil, K. R., Christina Bergqvist, A. G., Blackford, R., Buchhalter, J. R., Caraballo, R. H., Cross, J. H., Dahlin, M. G., et al. (2018) · Epilepsia Open · doi:10.1002/epi4.12225 · Cited by 768
Self-citationSymonds, J. D., Zuberi, S. M., Stewart, K., McLellan, A., O‘Regan, M., MacLeod, S., Jollands, A., Joss, S., Kirkpatrick, M., Brunklaus, A., et al. (2019) · Brain · doi:10.1093/brain/awz195 · Cited by 459
Self-citationLeen, W. G., Klepper, J., Verbeek, M. M., Leferink, M., Hofste, T., van Engelen, B. G., Wevers, R. A., Arthur, T., Bahi-Buisson, N., Ballhausen, D., et al. (2010) · Brain · doi:10.1093/brain/awp336 · Cited by 420
Self-citationOn the Metabolism of Exogenous Ketones in Humans
Stubbs, B. J., Cox, P. J., Evans, R. D., Santer, P., Miller, J. J., Faull, O. K., Magor-Elliott, S., Hiyama, S., Stirling, M., & Clarke, K. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00848 · Cited by 392
Weber, Y. G., Storch, A., Wuttke, T. V., Brockmann, K., Kempfle, J., Maljevic, S., Margari, L., Kamm, C., Schneider, S. A., Huber, S. M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34438 · Cited by 363
Phenotypic Spectrum of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
Pearson, T. S., Akman, C., Hinton, V. J., Engelstad, K., & De Vivo, D. C. (2013) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-013-0342-7 · Cited by 227
Self-citationBergqvist, A. C., Schall, J. I., Stallings, V. A., & Zemel, B. S. (2008) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26099 · Cited by 193
Efficacy of the classic ketogenic and the modified Atkins diets in refractory childhood epilepsy
Kim, J. A., Yoon, J., Lee, E. J., Lee, J. S., Kim, J. T., Kim, H. D., & Kang, H. (2016) · Epilepsia · doi:10.1111/epi.13256 · Cited by 187
Glucose transporter type I deficiency syndrome: Epilepsy phenotypes and outcomes
Pong, A. W., Geary, B. R., Engelstad, K. M., Natarajan, A., Yang, H., & De Vivo, D. C. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03592.x · Cited by 170
Self-citationLópez-Rivera, J. A., Pérez‐Palma, E., Symonds, J. D., Lindy, A. S., McKnight, D., Leu, C., Zuberi, S. M., Brunklaus, A., Møller, R. S., & Lal, D. (2020) · Brain · doi:10.1093/brain/awaa051 · Cited by 166
Self-citationAutosomal dominant Glut‐1 deficiency syndrome and familial epilepsy
Brockmann, K., Wang, D., Korenke, C. G., Von Moers, A., Ho, Y., Pascual, J. M., Kuang, K., Yang, H., Ma, L., Kranz‐Eble, P., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1222 · Cited by 163
Self-citationImaging the metabolic footprint of Glut1 deficiency on the brain
Pascual, J. M., Heertum, R. L. V., Wang, D., Engelstad, K., & Vivo, D. C. D. (2002) · Annals of Neurology · doi:10.1002/ana.10311 · Cited by 161
Self-citationGlucose transporters in healthy heart and in cardiac disease
Szablewski, L. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.12.083 · Cited by 159
GLUT1 deficiency syndrome in clinical practice
Klepper, J. (2011) · Epilepsy Research · doi:10.1016/j.eplepsyres.2011.02.007 · Cited by 145
Self-citationLeen, W. G., Willemsen, M. A. A. P., Wevers, R. A., & Verbeek, M. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042745 · Cited by 141
Self-citationSeizure Characterization and Electroencephalographic Features in Glut‐1 Deficiency Syndrome
Leary, L., Wang, D., Nordli, D. R., Engelstad, K., & Vivo, D. C. D. (2003) · Epilepsia · doi:10.1046/j.1528-1157.2003.05302.x · Cited by 140
Self-citationThe ketogenic diet in infants – Advantages of early use
Dressler, A., Trimmel‐Schwahofer, P., Reithofer, E., Gröppel, G., Mühlebner, A., Samueli, S., Grabner, V., Abraham, K., Benninger, F., & Feucht, M. (2015) · Epilepsy Research · doi:10.1016/j.eplepsyres.2015.06.015 · Cited by 133
Cerebrospinal Fluid Analysis in the Workup of GLUT1 Deficiency Syndrome: A Systematic Review
Leen, W. G., Wevers, R. A., Kamsteeg, E., Scheffer, H., Verbeek, M. M., & Willemsen, M. A. A. P. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.3090 · Cited by 133
Self-citationDietary treatment in adults with refractory epilepsy: A review
Klein, P., Tyrlíková, I., & Mathews, G. C. (2014) · Neurology · doi:10.1212/wnl.0000000000001004 · Cited by 133
Mutations in Disordered Regions Can Cause Disease by Creating Dileucine Motifs
Meyer, K., Kirchner, M., Uyar, B., Cheng, J.-Y., Russo, G., Hernandez-Miranda, L. R., Szymborska, A., Zauber, H., Rudolph, I.-M., Willnow, T. E., et al. (2018) · Cell · doi:10.1016/j.cell.2018.08.019 · Cited by 132
Self-citationEstablishing an Adult Epilepsy Diet Center: Experience, efficacy and challenges
Cervenka, M. C., Henry-Barron, B. J., Felton, E. A., Patton, K., & Kossoff, E. H. (2016) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2016.02.038 · Cited by 127
Self-citationTang, M., Gao, G., Rueda, C. B., Yu, H., Thibodeaux, D. N., Awano, T., Engelstad, K., Sanchez‐Quintero, M. J., Yang, H., Li, F., et al. (2017) · Nature Communications · doi:10.1038/ncomms14152 · Cited by 127
Self-citationParoxysmal choreoathetosis/spasticity (DYT9) is caused by a GLUT1 defect
Weber, Y. G., Kamm, C., Suls, A., Kempfle, J. S., Kotschet, K. E., Schüle, R., Wuttke, T. V., Maljevic, S., Liebrich, J., Gasser, T., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e31822e0479 · Cited by 124
Swarup, A., Samuels, I. S., Bell, B. A., Han, J. Y. S., Du, J., Massenzio, E., Abel, E. D., Boesze-Battaglia, K., Peachey, N. S., & Philp, N. J. (2019) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00410.2018 · Cited by 122
D,L-3-hydroxybutyrate treatment of multiple acyl-CoA dehydrogenase deficiency (MADD)
Hove, J. L. K. V., Grünewald, S., Jaeken, J., Demaerel, P., Declercq, P. E., Bourdoux, P. P., Niezen‐Koning, K. E., Deanfeld, J. E., & Leonard, J. V. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13105-4 · Cited by 121
von Wolff, M., Ursel, S., Hahn, U., Steldinger, R., & Strowitzki, T. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021890 · Cited by 119
Early onset absence epilepsy: 1 in 10 cases is caused by GLUT1 deficiency
Arsov, T., Mullen, S. A., Damiano, J. A., Lawrence, K. M., Huh, L. L., Nolan, M. A., Young, H., Thouin, A., Dahl, H. M., Berkovic, S. F., et al. (2012) · Epilepsia · doi:10.1111/epi.12007 · Cited by 117
Self-citationUse of dietary therapies amongst patients with GLUT1 deficiency syndrome
Kass, H. R., Winesett, S. P., Bessone, S. K., Turner, Z., & Kossoff, E. H. (2016) · Seizure · doi:10.1016/j.seizure.2016.01.011 · Cited by 117
Self-citationLong-Term Clinical Course of Glut1 Deficiency Syndrome
Alter, A. S., Engelstad, K., Hinton, V. J., Montes, J., Pearson, T. S., Akman, Ç. I., & Vivo, D. C. D. (2014) · Journal of Child Neurology · doi:10.1177/0883073814531822 · Cited by 104
Self-citationPascual, J. M., Liu, P., Mao, D., Kelly, D. I., Hernández, A., Sheng, M., Good, L. B., Ma, Q., Marin‐Valencia, I., Zhang, X., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.1584 · Cited by 101
Self-citationLarsen, J., Johannesen, K. M., Ek, J., Tang, S. S., Marini, C., Blichfeldt, S., Kibæk, M., von Spiczak, S., Weckhuysen, S., Frangu, M., et al. (2015) · Epilepsia · doi:10.1111/epi.13222 · Cited by 100
Marin‐Valencia, I., Good, L. B., Ma, Q., Malloy, C. R., & Pascual, J. M. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.151 · Cited by 98
Self-citationGLUT1 deficiency syndrome into adulthood: a follow-up study
Leen, W. G., Taher, M., Verbeek, M. M., Kamsteeg, E., van de Warrenburg, B. P. C., & Willemsen, M. A. A. P. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7240-z · Cited by 90
Self-citationTherapeutic strategies for glucose transporter 1 deficiency syndrome
Tang, M., Park, S. H., Vivo, D. C. D., & Monani, U. R. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.50881 · Cited by 83
Self-citationGLUT1-Deficiency: Barbiturates Potentiate Haploinsufficiency in Vitro
Klepper, J., Fischbarg, J., Vera, J. C., Wang, D., & Vivo, D. C. D. (1999) · Pediatric Research · doi:10.1203/00006450-199912000-00006 · Cited by 78
Self-citationConcomitant Treatment with Topiramate and Ketogenic Diet in Pediatric Epilepsy
Takeoka, M., Riviello, J. J., Pfeifer, H. H., & Thiele, E. A. (2002) · Epilepsia · doi:10.1046/j.1528-1157.2002.00602.x · Cited by 73
Autosomal Recessive Inheritance of GLUT1 Deficiency Syndrome
Klepper, J., Scheffer, H., Elsaid, M. F., Kamsteeg, E.-J., Leferink, M., & Ben‐Omran, T. (2009) · Neuropediatrics · doi:10.1055/s-0030-1248264 · Cited by 70
Self-citationKahn, B. B. (1994) · Journal of Nutrition · doi:10.1093/jn/124.suppl_8.1289s · Cited by 69
From splitting GLUT1 deficiency syndromes to overlapping phenotypes
Hully, M., Vuillaumier‐Barrot, S., Bizec, C. L., Boddaert, N., Kamińska, A., Lascelles, K., de Lonlay, P., Cancès, C., Portes, V. D., Roubertie, A., et al. (2015) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2015.06.007 · Cited by 68
Paroxysmal eye–head movements in Glut1 deficiency syndrome
Pearson, T. S., Pons, R. M., Engelstad, K., Kane, S., Goldberg, M. E., & Vivo, D. C. D. (2017) · Neurology · doi:10.1212/wnl.0000000000003867 · Cited by 65
Self-citationOverall cognitive profiles in patients with GLUT 1 Deficiency Syndrome
GIORGIS, V. D., Masnada, S., Varesio, C., Chiappedi, M. A., Zanaboni, M. P., Pasca, L., Filippini, M., Macasaet, J. A., Valente, M., Ferraris, C., et al. (2019) · Brain and Behavior · doi:10.1002/brb3.1224 · Cited by 64
Self-citationMarin‐Valencia, I., Good, L. B., Ma, Q., Duarte, J. A. G., Bottiglieri, T., Sinton, C. M., Heilig, C. W., & Pascual, J. M. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.04.011 · Cited by 62
Self-citationExcellent response to acetazolamide in a case of paroxysmal dyskinesias due to GLUT1-deficiency
Anheim, M., Maillart, É., Vuillaumier‐Barrot, S., Flamand‐Rouvière, C., Pineau, F., Ewenczyk, C., Riant, F., Apartis, E., & Roze, E. F. (2010) · Journal of Neurology · doi:10.1007/s00415-010-5702-5 · Cited by 60
Ho, Y.-Y., Yang, H., Klepper, J., Fischbarg, J., Wang, D., & Vivo, D. C. D. (2001) · Pediatric Research · doi:10.1203/00006450-200108000-00015 · Cited by 58
Self-citationStructural Signatures and Membrane Helix 4 in GLUT1
Pascual, J. M., Wang, D., Yang, R., Shi, L., Yang, H., & Vivo, D. C. D. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801403200 · Cited by 57
Self-citationComan, D. J., Sinclair, K., Cj, B., Db, A., Pelekanos, J. T., O’Neil, C., Wallace, G., Bowling, F. G., Wang, D., Vivo, D. C. D., et al. (2006) · Journal of Paediatrics and Child Health · doi:10.1111/j.1440-1754.2006.00852.x · Cited by 55
Urolithiasis on the ketogenic diet with concurrent topiramate or zonisamide therapy
Paul, E., Conant, K. D., Dunne, I. E., Pfeifer, H. H., Lyczkowski, D. A., Linshaw, M. A., & Thiele, E. A. (2010) · Epilepsy Research · doi:10.1016/j.eplepsyres.2010.04.005 · Cited by 55
Sporadic and familial glut1ds Italian patients: A wide clinical variability
GIORGIS, V. D., Teutonico, F., Cereda, C., Balottin, U., Bianchi, M., Giordano, L., Olivotto, S., Ragona, F., Tagliabue, A., Zorzi, G. S., et al. (2014) · Seizure · doi:10.1016/j.seizure.2014.11.009 · Cited by 52
Self-citationNationwide survey of glucose transporter-1 deficiency syndrome (GLUT-1DS) in Japan
Ito, Y., Takahashi, S., Kagitani‐Shimono, K., Natsume, J., Yanagihara, K., Fujii, T., & Oguni, H. (2014) · Brain and Development · doi:10.1016/j.braindev.2014.11.006 · Cited by 51
Self-citationTriheptanoin for the treatment of brain energy deficit: A 14‐year experience
Mochel, F. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.24111 · Cited by 50
Effects of anticonvulsants on GLUT1-mediated glucose transport in GLUT1 deficiency syndrome in vitro
Klepper, J., Flörcken, A., Fischbarg, J., & Voït, T. (2003) · European Journal of Pediatrics · doi:10.1007/s00431-002-1112-8 · Cited by 49
Self-citationHeußinger, N., Marina, A. D., Beyerlein, A., Leiendecker, B., Hermann-Alves, S., Pozza, R. D., & Klepper, J. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2017.11.001 · Cited by 46
Self-citationPascual, J. M., & Ronen, G. M. (2015) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2015.08.001 · Cited by 40
Self-citationGLUT1 Deficiency With Delayed Myelination Responding to Ketogenic Diet
Klepper, J., Engelbrecht, V., Scheffer, H., van der Knaap, M. S., & Fiedler, A. (2007) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2007.03.009 · Cited by 39
Self-citationTopography of brain glucose hypometabolism and epileptic network in glucose transporter 1 deficiency
Akman, Ç. I., Provenzano, F. A., Wang, D., Engelstad, K., Hinton, V. J., Yu, J., Tikofsky, R. S., Ichese, M., & Vivo, D. C. D. (2014) · Epilepsy Research · doi:10.1016/j.eplepsyres.2014.11.007 · Cited by 38
Self-citationAcute hyperglycemia produces transient improvement in glucose transporter type 1 deficiency
Akman, Ç. I., Engelstad, K., Hinton, V. J., Ullner, P. M., Koenigsberger, D. Y., Leary, L., Wang, D., & Vivo, D. C. D. (2009) · Annals of Neurology · doi:10.1002/ana.21797 · Cited by 38
Self-citationA simple blood test expedites the diagnosis of glucose transporter type 1 deficiency syndrome
Gras, D., Cousin, C., Kappeler, C., et al. (2017) · Annals of Neurology · doi:10.1002/ana.24970 · Cited by 37
Wolking, S., Becker, F., Bast, T., Wiemer‐Kruel, A., Mayer, T., Lerche, H., & Weber, Y. G. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7433-5 · Cited by 34
van der Louw, E. J. T. M., Desadien, R., Vehmeijer, F. O. L., van der Sijs, H., Catsman‐Berrevoets, C. E., & Neuteboom, R. F. (2015) · Seizure · doi:10.1016/j.seizure.2015.09.007 · Cited by 33
Glut1 deficiency: CSF glucose. How low is too low?
Vivo, D. C. D., & Wang, D. (2008) · Revue Neurologique · doi:10.1016/j.neurol.2008.10.001 · Cited by 33
Dystonic tremor caused by mutation of the glucose transporter gene GLUT1
Roubergue, A., Apartis, E., Mesnage, V., Doummar, D., Trocello, J., Roze, E. F., Taïeb, G., de Villemeur, T. B., Vuillaumier‐Barrot, S., Vidailhet, M., et al. (2011) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-010-9264-6 · Cited by 32
A novel SLC2A1 mutation linking hemiplegic migraine with alternating hemiplegia of childhood
Weller, C. M., Leen, W. G., Neville, B. G., et al. (2014) · Cephalalgia · doi:10.1177/0333102414532379 · Cited by 32
Self-citationLloyd, K. P., Ojelabi, O., Zutter, J. K. D., & Carruthers, A. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.815589 · Cited by 31
Impact of the modified Atkins diet on cardiovascular health in adults with epilepsy
McDonald, T. J. W., Ratchford, E. V., Henry-Barron, B. J., Kossoff, E. H., & Cervenka, M. C. (2017) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2017.10.035 · Cited by 31
Self-citationUpstream SLC2A1 translation initiation causes GLUT1 deficiency syndrome
Willemsen, M. A. A. P., Vissers, L. E. L. M., Verbeek, M. M., van Bon, B. W. M., Geuer, S., Gilissen, C., Klepper, J., Kwint, M. P., Leen, W. G., Pennings, M., et al. (2017) · European Journal of Human Genetics · doi:10.1038/ejhg.2017.45 · Cited by 29
Self-citationChild Neurology: Differential diagnosis of a low CSF glucose in children and young adults
Leen, W. G., de Wit, C. J., Wevers, R. A., et al. (2013) · Neurology · doi:10.1212/01.wnl.0000437294.20817.99 · Cited by 27
Self-citationOxidation of [U‐13C]glucose in the human brain at 7T under steady state conditions
Cheshkov, S., Dimitrov, I. E., Jakkamsetti, V., Good, L. B., Kelly, D. I., Rajasekaran, K., DeBerardinis, R. J., Pascual, J. M., Sherry, A. D., & Malloy, C. R. (2017) · Magnetic Resonance in Medicine · doi:10.1002/mrm.26603 · Cited by 27
Self-citationNakamura, S., Muramatsu, S., Takino, N., Ito, M., Jimbo, E. F., Shimazaki, K., Onaka, T., Ohtsuki, S., Terasaki, T., Yamagata, T., et al. (2018) · The Journal of Gene Medicine · doi:10.1002/jgm.3013 · Cited by 27
Functional consequences of the autosomal dominant G272A mutation in the human GLUT1 gene
Klepper, J., Monden, I., Guertsen, E., Voït, T., Willemsen, M. A. A. P., & Keller, K. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02463-2 · Cited by 23
Self-citationRaja, M., & Kinne, R. K. H. (2020) · The Journal of Membrane Biology · doi:10.1007/s00232-020-00108-3 · Cited by 23
Brain correlates of spike and wave discharges in GLUT1 deficiency syndrome
Vaudano, A. E., Olivotto, S., Ruggieri, A., Gessaroli, G., GIORGIS, V. D., Parmeggiani, A., Veggiotti, P., & Meletti, S. (2016) · NeuroImage Clinical · doi:10.1016/j.nicl.2016.12.026 · Cited by 20
Self-citationIs there a role for diet monotherapy in adult epilepsy?
Cervenka, M. C., Henry-Barron, B. J., & Kossoff, E. H. (2016) · Epilepsy & Behavior Case Reports · doi:10.1016/j.ebcr.2016.09.005 · Cited by 19
Self-citationGLUT-1 deficiency presenting with seizures and reversible leukoencephalopathy on MRI imaging
Ismayilova, N., Hacohen, Y., MacKinnon, A. D., et al. (2018) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2018.02.002 · Cited by 18
Evaluation of GLUT1 variation in non-acquired focal epilepsy
Peeraer, A., Damiano, J. A., Bellows, S. T., Scheffer, I. E., Berkovic, S. F., Mullen, S. A., & Hildebrand, M. S. (2017) · Epilepsy Research · doi:10.1016/j.eplepsyres.2017.04.007 · Cited by 7
Self-citationWong, H. Y., Chu, T. S., Chan, J. Y., Fok, T. F., Fung, L. W. E., Fung, K., & Ho, Y.-Y. (2005) · Life Sciences · doi:10.1016/j.lfs.2004.10.032 · Cited by 6
Cited by
Zuberi, S. M., Wirrell, E., Yozawitz, E., Wilmshurst, J. M., Specchio, N., Riney, K., Pressler, R., Auvin, S., Samia, P., Hirsch, E., et al. (2022) · Epilepsia · doi:10.1111/epi.17239 · Cited by 934
Self-citationTherapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed?
Engelen, S. E., Robinson, A. J. B., Zurke, Y.-X., & Monaco, C. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00668-4 · Cited by 425
PURA and GLUT1: Sweet partners for brain health
Colombo, R. B., Maxit, C., Martinelli, D., Anderson, M., Masone, D., & Mayorga, L. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167261 · Cited by 5
Metadata
- Authors
- Klepper, J., Akman, C., Armeno, M., Auvin, S., Cervenka, M., Cross, H. J., De Giorgis, V., Della Marina, A., Engelstad, K., Heussinger, N., Kossoff, E. H., Leen, W. G., Leiendecker, B., Monani, U. R., Oguni, H., Neal, E., Pascual, J. M., Pearson, T. S., Pons, R., Scheffer, I. E., Veggiotti, P., Willemsen, M., Zuberi, S. M., & De Vivo, D. C.
- Venue
- Epilepsia Open
- Publisher
- Wiley
- Published
- 2020-08-13
- Volume
- 5
- Issue
- 3
- Pages
- 354-365
- ISSN
- 2470-9239 (ISSN-L)
- OpenAlex
- W3037444348
- Cited by
- 285
- References
- 76
- FWCI
- 16.59
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.